Eve & Co Announces German Supply Agreement TORONTO, Jan.

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
18
Eve & Co Announces German Supply Agreement

TORONTO, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (the “Company” or “Eve & Co”) (TSXV: EVE; OTCQB: EEVVF) is pleased to announce that its wholly-owned subsidiary Natural MedCo Ltd. has entered into a binding non-exclusive supply agreement for the sale of dried cannabis to an established German importer and distributor of parapharmaceutical and medicinal products.

The supply agreement is for an initial term of three years and is automatically renewable for two subsequent two-year terms unless otherwise terminated by the parties at the end of the initial or renewal term.  The German distributor has agreed to purchase a minimum of 2,250 kilograms of dried cannabis over the initial two year period and can increase the amount ordered on the acceptance by Eve & Co.  The parties expect the first shipments to commence in Q1 2019.

“This agreement is an important milestone for us in our expansion into international markets.  We are very pleased to be working with an established and reputable firm to access the German market where pricing continues to be at a substantial premium to local markets.  We are excited to continue to develop opportunities for Natural MedCo and the EVE brand across multiple global markets," said Melinda Rombouts, President and Chief Executive Officer of Eve & Co.

The purchase and sale of dried cannabis under the supply agreement are subject to various conditions precedent, including receipt of all requisite regulatory approvals, including applicable Canadian and Germany export and import authorizations.

ABOUT EVE & CO INCORPORATED

Eve & Co, through its wholly-owned subsidiary Natural MedCo Ltd., holds cultivation and processing licenses under the Cannabis Act (Canada) for the production and sale of various cannabis products, including dried cannabis, cannabis plants and cannabis oil. Natural MedCo Ltd. was Canada’s first female founded licensed producer of medicinal marijuana and received its cultivation license from Health Canada in 2016.

Eve & Co is led by a team of agricultural experts and has a licenced 220,000 sq. ft. scalable greenhouse production facility located in Middlesex County, Ontario with 32 acres of adjacent land for future expansion. Eve & Co has commenced construction of an additional 780,000 sq. ft. proposed expansion, bringing Eve & Co’s total anticipated greenhouse capacity to 1,000,000 sq. ft.

The TSXV has neither approved nor disapproved the contents of this news release. Neither the TSXV nor its Regulation Service Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

Certain statements in this press release constitute forward-looking information. All statements other than statements of historical fact contained in this press release, including, without limitation, those regarding the Company’s 780,000 sq. ft. expansion and funding therefor, future, strategy, plans, objectives, goals and targets, ability to execute on its export sales, and any statements preceded by, followed by or that include the words “believe”, “expect”, “aim”, “intend”, “plan”, “continue”, “will”, “may”, “would”, “anticipate”, “estimate”, “forecast”, “predict”, “project”, “seek”, “should” or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company’s expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict, including those described in the Company’s filing statement dated June 18, 2018 and available on the Company’s SEDAR profile. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. The forward-looking information and forward-looking statements included in this news release are made as of the date of this news release the Company does not undertake an obligation to publicly update such forward-looking information or forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities law.

For further information, please contact:

Melinda Rombouts
President and Chief Executive Officer
Eve & Co Incorporated
Telephone: (855) 628-6337
 
Landon Roedding
Chief Financial Officer
Eve & Co Incorporated
Telephone: (647) 473-4947
Scroll down for more posts ▼

Top 10 Most Recent News Articles

RingConn Joins BVB Women's Team: Tech Meets Sport

Updated Category News Views 64

Tech and Football: An Unlikely Alliance Alright, so here's a story that might perk your ears up—RingConn, a relative newcomer in the health tech world, has chosen to stake its future on a bet with Borussia Dortmund's women's football team. This isn't just your average brand-sponsorship slap-on-the-shirt deal; we're looking at a potential game-changer here, folks. Who...

Continue Reading
CVS Health to Split: New Paths for Growth

Updated Category News Views 64

The Evolution of CVS Health Walking through CVS Health's latest move feels like watching a torch split into two flames, each set to shine its own light in the healthcare industry. This behemoth of pharmacy and healthcare solutions is gearing up to divide into two independent, publicly traded entities by the first half of 2028. A decision not made lightly, this separation...

Continue Reading
Life with PAH: A Journey of Awareness and Hope

Updated Category News Views 224

Unearthing the Hidden Struggle of PAH The American Lung Association (ALA) is getting loud about a quiet killer—pulmonary arterial hypertension (PAH) is in their spotlight this month, and it's about time. Documenting the horror stories of some 500 to 1,000 new PAH diagnoses each year in the U.S., the ALA is peeling back the blinds on a condition that's too often...

Continue Reading
Stellar Snacks Shakes Up Pretzel Sector with Bold Launch

Updated Category News Views 48

Stellar Snacks' audacious venture into olive oil-based pretzels Ever thought pretzels would stir up a storm? Well, Stellar Snacks sure did. They're celebrating a blockbuster year by rolling out a brand-new line of olive oil-baked pretzel braids across Sprouts Farmers Market nationwide. This isn't just any rollout. It's a carefully crafted endeavor tailored to redefine how...

Continue Reading
Mazu Forum: Bridging Cultures and Marine Safety

Updated Category News Views 93

The 11th Global Mazu Culture Forum kicked off on November 1 in Putian City, Fujian Province—smack dab on the historical Meizhou Island. This ain’t just another talk-fest; it's a melting pot of ideas and achievements packaged with cultural flair and some serious tech muscle. Nestled in China's southeast, Meizhou Island serves as the heartland for Mazu culture, a beacon...

Continue Reading
Black Friday Doubt Grows: Just 54% Trust Real Deals

Updated Category News Views 93

Do Shoppers Believe in Black Friday Anymore? You'd think by now, retailers would have cracked the code on building trust with their customers. But guess what? A fresh survey from Boston Consulting Group reveals only 54% of consumers buy the whole Black Friday discount story. That's barely more than flipping a coin. Promotion Fatigue: The Trust Buster Funny thing,...

Continue Reading
Are BWIN, LFCR, PCRX Shareholder Deals Fair?

Updated Category News Views 113

What's Really Going On with BWIN, LFCR, and PCRX? Everyone talks about when there's smoke, there's fire. But in this case, it’s hard not to wonder if we're standing knee-deep in burning embers, or just a dusty old campfire. Halper Sadeh LLC is ringing the alarm bells for Baldwin Group, Lifecore Biomedical, and Pacira BioSciences, the trio tagged under NASDAQ: BWIN,...

Continue Reading
Hugel's Sales Climb Despite Changes in Sales Models

Updated Category News Views 117

Hugel's Financial Fortunes in a Shifting Landscape Who would've thought? That’s the vibe hugging the numbers Hugel Inc. just dropped. Their performance for the first three quarters of 2026 is in the books, and results show consolidated net sales climbing 15% year-on-year. Just how did they pull this rabbit out of the hat? Let's dissect this a bit. Cracking the Code of...

Continue Reading
UP Fintech Faces Class Action: What's at Stake?

Updated Category News Views 32

Deep Dive into UP Fintech's Tumultuous Journey Let me tell you, nothing quite shakes the confidence like a stock dropping over 25% overnight. The folks invested in UP Fintech Holding Limited (NASDAQ: TIGR) are likely feeling that gut-wrenching sensation right about now. With a securities fraud class action tossed on the table against them, you can be sure the road ahead...

Continue Reading
Sebastian & Boiler Room's Bold Dive into Creative Synergy

Updated Category News Views 59

Call it a wild cosmic union or just a sharp, savvy partnership—either way, Sebastian Professional and Boiler Room have teamed up in a bold celebration of creativity that could shake things up. By leveraging their own unique legacies, they're producing "Centre Stage," a fresh content series spotlighting the explosive synergy where music and hair artistry meet. This...

Continue Reading

Top 5 Most Recently Viewed Articles

Experience Italy's Wine Legacy at OperaWine Event 2026

Updated Category News Views 113

Discover the Richness of Italian Wines at OperaWine 2026 OperaWine, known as the premier event of Vinitaly, is set to provide an unforgettable experience for wine enthusiasts and professionals. This highly anticipated event showcases Italy's finest wines, curated by Wine Spectator, a magazine renowned for its expertise in the wine industry. On the remarkable day of the...

Continue Reading
Anticipating Earnings: Insights on Cognyte Software's Future

Updated Category News Views 213

Cognyte Software's Earnings Overview Cognyte Software (NASDAQ: CGNT) is on the verge of releasing its latest quarterly earnings report, and investor anticipation is palpable. With analysts estimating earnings per share (EPS) to be approximately $0.03, many are keen to see if the company meets or exceeds these expectations. What Investors Should Watch For For those holding...

Continue Reading
Cassava Sciences Settles SEC Inquiry on Clinical Trial Claims

Updated Category News Views 183

Cassava Sciences, Inc. (NASDAQ: SAVA) took a hit back in 2024 when the U. S. Securities and Exchange Commission (SEC) wrapped up its investigation into the company’s past disclosures. The SEC alleged that Cassava had been negligent regarding its reporting on the 2020 Phase 2b clinical trial results for simufilam, a drug touted as a potential game-changer in...

Continue Reading
AmpliTech Group Unveils Next-Gen Ultra Low Noise Amplifiers

Updated Category News Views 223

AmpliTech Group Introduces Advanced Ultra Low Noise Amplifiers AmpliTech Group, Inc. (NASDAQ: AMPG, AMPGW), a prominent designer and manufacturer specializing in signal processing components, proudly announces the successful delivery of prototype high-frequency Ultra Low Noise Amplifiers (ULNAs) to a major satellite network provider. These innovative amplifiers are...

Continue Reading
OneDigital Appoints Bill Carew and Camry Blaising as Leaders

Updated Category News Views 164

OneDigital Strengthens Leadership with New Executive Appointments Bill Carew Named President; Camry Blaising Named Chief Operating Officer Based in Atlanta, OneDigital, a prominent insurance brokerage and HR consulting firm, has made significant executive appointments aimed at fostering growth and operational excellence. Bill Carew has been elevated to the position of...

Continue Reading